These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 21234853)
1. Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls. Cho LW; Kilpatrick ES; Keevil BG; Jayagopal V; Coady AM; Rigby AS; Atkin SL Horm Metab Res; 2011 Feb; 43(2):141-5. PubMed ID: 21234853 [TBL] [Abstract][Full Text] [Related]
2. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589 [TBL] [Abstract][Full Text] [Related]
3. Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome. Amato MC; Verghi M; Nucera M; Galluzzo A; Giordano C Gynecol Endocrinol; 2011 Aug; 27(8):579-86. PubMed ID: 20608809 [TBL] [Abstract][Full Text] [Related]
4. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome. Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221 [TBL] [Abstract][Full Text] [Related]
5. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Carmina E; Lobo RA Fertil Steril; 2004 Sep; 82(3):661-5. PubMed ID: 15374711 [TBL] [Abstract][Full Text] [Related]
6. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations. Koo YA; Shin SY; Yoon BK; Choi D Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414 [TBL] [Abstract][Full Text] [Related]
7. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189 [TBL] [Abstract][Full Text] [Related]
8. The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetes. Cho LW; Jayagopal V; Kilpatrick ES; Atkin SL Ann Clin Biochem; 2009 May; 46(Pt 3):218-21. PubMed ID: 19389885 [TBL] [Abstract][Full Text] [Related]
9. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. Sepilian V; Nagamani M J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109 [TBL] [Abstract][Full Text] [Related]
10. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Ardawi MS; Rouzi AA Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome. Lankarani M; Valizadeh N; Heshmat R; Peimani M; Sohrabvand F Gynecol Endocrinol; 2009 Aug; 25(8):504-7. PubMed ID: 19499403 [TBL] [Abstract][Full Text] [Related]
12. Body fat composition and distribution in women with polycystic ovary syndrome. Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379 [TBL] [Abstract][Full Text] [Related]
13. Does ovarian blood flow distinguish between ovulatory and anovulatory patients with polycystic ovary syndrome? Carmina E; Longo A; Lobo RA Am J Obstet Gynecol; 2003 Nov; 189(5):1283-6. PubMed ID: 14634554 [TBL] [Abstract][Full Text] [Related]
14. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [TBL] [Abstract][Full Text] [Related]
15. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women. Anaforoglu I; Algun E; Incecayir O; Ersoy K Metab Syndr Relat Disord; 2011 Oct; 9(5):375-80. PubMed ID: 21657888 [TBL] [Abstract][Full Text] [Related]
16. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome. Takeuchi T; Tsutsumi O; Taketani Y Gynecol Endocrinol; 2008 Jul; 24(7):385-91. PubMed ID: 18645711 [TBL] [Abstract][Full Text] [Related]
17. [Detection and significance of phosphatidylinositol 3-kinase in adipose tissue of polycystic ovary syndrome patients with insulin resistance]. Chu YL; Qiu HY; Sun YY; Li M; Li HF Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):455-8. PubMed ID: 17083810 [TBL] [Abstract][Full Text] [Related]
18. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome. Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome. Savastano S; Orio F; Palomba S; Cascella T; Manguso F; Lupoli GA; Formisano P; Lombardi G; Colao A; Beguinot F; Valentino R Clin Endocrinol (Oxf); 2007 Oct; 67(4):557-62. PubMed ID: 17590172 [TBL] [Abstract][Full Text] [Related]
20. Glucose intolerance in Japanese patients with polycystic ovary syndrome. Kurioka H; Takahashi K; Miyazaki K Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]